The Food and Drug Administration Biologics Effectiveness and Safety Initiative Facilitates Detection of Vaccine Administrations From Unstructured Data in Medical Records Through Natural Language Processing

• Váldodahkkit: Matthew Deady (Dahkki), Hussein Ezzeldin (Dahkki), Kerry Cook (Dahkki), Douglas Billings (Dahkki), Jeno Pizarro (Dahkki), Amalia A. Plotogea (Dahkki), Patrick Saunders-Hastings (Dahkki), Artur Belov (Dahkki), Barbee I. Whitaker (Dahkki), Steven A. Anderson (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction: The Food and Drug Administration Center for Biologics Evaluation and Research conducts post-market surveillance of biologic products to ensure their safety and effectiveness. Studies have found that common vaccine exposures may be missing from structured data elements of electronic hea...